A Dr Fong colt and an Orpen filly tied for the highest price of €115,000 ($154,302 in United States funds) at the first edition of the Arqana v.2 yearling sale Aug. 20 in Deauville.
The new sale, the focus of which was precocious-type yearlings likely to race at age 2, immediately followed Arqana's elite August yearling sale, which closed Aug. 19 with double-digit gains across the board and a record average price. Sale company officials were pleased with how the v.2 sale was received by buyers and consignors.
"We are delighted with this first vintage of the sale, which fulfilled all the objectives we had set ourselves and which posted very satisfactory figures, including a percentage of horses sold nearing 80%," Arqana chairman Eric Hoyeau said. "French bloodstock agents and trainers were present while numerous buyers who were already active on the three days of the previous sale made new purchases."
Overall, 86 of 108 horses offered were sold for total receipts of €2,352,500 ($3,156,630). The average price was €27,623 ($37,065) and the median was €20,000 ($26,837).
Guillaume Gorse of Hautieres Bloodstock purchased the Dr Fong colt on behalf of client from Kazakhstan. The youngster, who was offered by Eric Lhermite's Haras de Grandcamp, is a half brother 2013 Prix Robert Papin (Fr-II) winner Vorda, an Orpen filly who recently finished second as the favorite in Darley Prix Morny (Fr-I) at Deauville.
Among bidders vying for the colt out of the winning Observatory mare Velda was Sylvain Vidal acting on behalf of Gerard Augustin Normand, who at one time was the owner Vorda.
The co-session topping Orpen filly was knocked down to Marc-Antoine Berghgracht's MAB Agency bidding against bloodstock agent David Redvers. The filly was acquired for clients Tony Forde and Ahmed Mouknass.
Out of the unraced Peintre Celebre mare Anatolie, the filly is from the family of Zagora, the Eclipse Award winner as champion turf female of 2012. She was consigned by Antoine Lepeudry's Elevage de Tourgeville.